TY  - CHAP
M1  - Book, Section
TI  - Nephritic Spectrum Glomerular Diseases
A1  - Dirkx, Tonja C.
A1  - Woodell, Tyler B.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - Key  Clinical  Updates  in  Nephritic  Spectrum  Glomerular  DiseasesSGLT2-inhibitors  may  be  added  to  standard  care  in  the  well-selected  patient.  Corticosteroids  for  reducing  proteinuria  and  slowing  progression;  however,  may  be  considered  for  patients  with  GFR  greater  than  30  mL/min/1.73  m2  and  persistent  proteinuria  greater  than  1  g/day  despite  maximal  ACE  inhibitor  or  ARB.Cheung  CK  et  al.  J  Clin  Med.  [PMID:  34200024]  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193127290
ER  -